These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 17033962)
21. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex]. Lunardi J; Monnier N Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S70-7. PubMed ID: 15269663 [TBL] [Abstract][Full Text] [Related]
22. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility. Taylor A; Lachlan K; Manners RM; Lotery AJ J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266 [TBL] [Abstract][Full Text] [Related]
23. [Hot spot mutation screening of RYR1 gene in diagnosis of congenital myopathies]. Chang XZ; Jin YW; Wang JM; Yuan Y; Xiong H; Wang S; Qin J Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):691-7. PubMed ID: 25331388 [TBL] [Abstract][Full Text] [Related]
24. Samaritan myopathy, an ultimately benign congenital myopathy, is caused by a RYR1 mutation. Böhm J; Leshinsky-Silver E; Vassilopoulos S; Le Gras S; Lerman-Sagie T; Ginzberg M; Jost B; Lev D; Laporte J Acta Neuropathol; 2012 Oct; 124(4):575-81. PubMed ID: 22752422 [TBL] [Abstract][Full Text] [Related]
25. Mutations in RYR1 in malignant hyperthermia and central core disease. Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943 [TBL] [Abstract][Full Text] [Related]
26. Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Davis MR; Haan E; Jungbluth H; Sewry C; North K; Muntoni F; Kuntzer T; Lamont P; Bankier A; Tomlinson P; Sánchez A; Walsh P; Nagarajan L; Oley C; Colley A; Gedeon A; Quinlivan R; Dixon J; James D; Müller CR; Laing NG Neuromuscul Disord; 2003 Feb; 13(2):151-7. PubMed ID: 12565913 [TBL] [Abstract][Full Text] [Related]
27. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms. Duarte ST; Oliveira J; Santos R; Pereira P; Barroso C; Conceição I; Evangelista T Muscle Nerve; 2011 Jul; 44(1):102-8. PubMed ID: 21674524 [TBL] [Abstract][Full Text] [Related]
28. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene. Fischer D; Herasse M; Ferreiro A; Barragán-Campos HM; Chiras J; Viollet L; Maugenre S; Leroy JP; Monnier N; Lunardi J; Guicheney P; Fardeau M; Romero NB Neurology; 2006 Dec; 67(12):2217-20. PubMed ID: 17190947 [TBL] [Abstract][Full Text] [Related]
31. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies. Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678 [TBL] [Abstract][Full Text] [Related]
32. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor. Avila G; Dirksen RT J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458 [TBL] [Abstract][Full Text] [Related]
34. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989 [TBL] [Abstract][Full Text] [Related]
35. A homozygous splicing mutation causing a depletion of skeletal muscle RYR1 is associated with multi-minicore disease congenital myopathy with ophthalmoplegia. Monnier N; Ferreiro A; Marty I; Labarre-Vila A; Mezin P; Lunardi J Hum Mol Genet; 2003 May; 12(10):1171-8. PubMed ID: 12719381 [TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic analysis of skeletal muscles from wild-type and transgenic mice carrying recessive Eckhardt J; Ruiz A; Koenig S; Frieden M; Meier H; Schmidt A; Treves S; Zorzato F Elife; 2023 Mar; 12():. PubMed ID: 36862731 [TBL] [Abstract][Full Text] [Related]
37. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease. Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353 [TBL] [Abstract][Full Text] [Related]
38. Parental mosaicism in RYR1-related Central Core Disease. Marks S; van Ruitenbeek E; Fallon P; Johns P; Phadke R; Mein R; Mohammed S; Jungbluth H Neuromuscul Disord; 2018 May; 28(5):422-426. PubMed ID: 29576327 [TBL] [Abstract][Full Text] [Related]
39. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia. Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222 [TBL] [Abstract][Full Text] [Related]
40. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel. Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]